1. Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma
   Chung-Ying Tsai et al, 2021, Biomedicines CrossRef
2. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer
   Zhenyu Xu et al, 2016, OncoImmunology CrossRef
3. Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms
   N. E. Kushlinskii et al, 2021, Almanac of Clinical Medicine CrossRef
4. Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies
   Wanyao Wang et al, 2024, Frontiers in Immunology CrossRef
5. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers
   Luiz Antonio Lupi et al, 2020, Life Sciences CrossRef
6. Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
   Ankur Chakravarthy et al, 2022, Nature Communications CrossRef
7. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis
   Hang Su et al, 2024, Taiwanese Journal of Obstetrics and Gynecology CrossRef
8. B7-H4, a promising target for immunotherapy
   Jia-Yu Wang et al, 2020, Cellular Immunology CrossRef
9. B7-H3 targeted antibody-based immunotherapy of malignant diseases
   Theodoros Michelakos et al, 2021, Expert Opinion on Biological Therapy CrossRef
10. Expression of immunomodulator programmed death ligand 1 and fork head box protein 3 in squamous cell carcinoma of cervix
    Mona M. Ahmed et al, 2018, Egyptian Journal of Pathology CrossRef
11. The third group of the B7‐CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7‐H3
    Murali Janakiram et al, 2017, Immunological Reviews CrossRef
12. B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis
    Zibo Meng et al, 2017, Oncotarget CrossRef
13. Expression of B7 family checkpoint proteins in cervical cancer
    Liju Zong et al, 2022, Modern Pathology CrossRef
14. Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance
    Yao Sun et al, 2024, The Journal of Pathology: Clinical Research CrossRef
15. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
    Peixin Dong et al, 2018, Frontiers in Oncology CrossRef
16. The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells
    Xiaotian Yan et al, 2021, Frontiers in Oncology CrossRef
17. The role of B7-H3 in tumors and its potential in clinical application
    Ranran Feng et al, 2021, International Immunopharmacology CrossRef
18. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
    Ioannis-Alexios Koumprentziotis et al, 2024, Vaccines CrossRef
19. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
    Elodie Picarda et al, 2016, Clinical Cancer Research CrossRef
20. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
    Xianyun Zhang et al, 2017, Oncotarget CrossRef
21. The Role of CD276 in Cancers
    Shengzhuo Liu et al, 2021, Frontiers in Oncology CrossRef
22. B7-H3 Immune Checkpoint Protein in Human Cancer
    Karine Flem-Karlsen et al, 2020, Current Medicinal Chemistry CrossRef
23. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer
    Shanshan Wu et al, 2016, Oncotarget CrossRef
24. Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
    Ali N. Kamali et al, 2023, Therapeutic Advances in Vaccines and Immunotherapy CrossRef
25. mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Heng-Jia Liu et al, 2023, Nature Communications CrossRef
26. The prognostic value of B7-H4 in pancreatic cancer
    Xin Chen et al, 2018, Medicine CrossRef
27. Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
    Qianqian Zhang et al, 2021, OncoTargets and Therapy CrossRef
28. Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
    Maryam Oroujeni et al, 2022, Pharmaceutics CrossRef